实用肝脏病杂志 ›› 2024, Vol. 27 ›› Issue (2): 246-250.doi: 10.3969/j.issn.1672-5069.2024.02.022

• 肝硬化 • 上一篇    下一篇

一组非肝硬化性门静脉高压症病因分析和诊断路径探讨*

冯彦菲, 苏明华, 殷倩冰, 黎清梅, 苏土梅, 梁蘅恺, 韦璐, 黄建芳, 江建宁   

  1. 530021 南宁市 广西医科大学第一附属医院感染性疾病科
  • 收稿日期:2023-04-20 出版日期:2024-02-10 发布日期:2024-03-08
  • 通讯作者: 江建宁,E-mail:jjianning@163.com
  • 作者简介:冯彦菲,女,26岁,硕士研究生。E-mail:fyanfei0320@163.com
  • 基金资助:
    *国家自然科学基金资助项目(编号:81960115,82260124);广西壮族自治区病毒性肝炎防治研究重点实验室开放课题基金项目(编号:GXCDCKL202001);教育部区域性高发肿瘤早期防治研究重点实验室自主课题(编号:GKE-ZZ202107)

Etiology and diagnostic roadmap in patients with non-cirrhotic portal hypertension

Feng Yanfei, Su Minghua, Yin Qianbin, et al.   

  1. Department of Infectious Diseases, First Affiliated Hospital, Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China
  • Received:2023-04-20 Online:2024-02-10 Published:2024-03-08

摘要: 目的 分析一组非肝硬化性门静脉高压(NCPH)患者的病因和诊断方法, 归纳总结诊断路径。方法 2020年9月~2022年3月广西医科大学第一附属医院收治的NCPH患者105例, 常规临床检查和基因分析诊断。结果 本组经综合检查, 诊断肝前型69例(65.7%), 肝内型21例(20.0%)、肝后型4例(3.8%)和未诊断11例(10.5);常见疾病为胰源性疾病22例(31.9%), 门静脉阻塞15例(21.7%), 血液性疾病15例(21.7%);主要诊断方法为影像学检查28例(40.6%), 消化内镜检查14例(20.3%), 骨髓穿刺活检术12例(17.4%);NCPH病因诊断前三位的方法依次为影像学检查(33.3%)、综合分析(18.1%)和消化内镜(13.9%)检查。结论 NCPH以肝前型门静脉高压为常见, 常规行实验室和影像学检查, 必要时行消化内镜和骨髓穿刺活检术可明确诊断。对于常规检查仍不能诊断的, 再考虑肝内型和肝后型门静脉高压, 行肝穿刺活检或下腔静脉穿刺造影等检查往往能进一步明确诊断。

关键词: 非肝硬化性门静脉高压, 病因, 诊断路径

Abstract: Objective The aim of this study was to investigate the etiology and diagnostic roadmap in patients with non-cirrhotic portal hypertension (NCPH). Methods 105 patients with NCPH were encountered in the First Affiliated Hospital, Guangxi Medical University between September 2020 and March 2022, and the etiologies and the main diagnostic methods were summarized retrospectively. Results The etiologies of NCPH in our series included prehepatic, hepatic and posthepatic entities; the common diseases were found with prehepatic portal hypertension (PH) in 69 cases (65.7%), the hepatic PH in 21 cases (20.0%) and the posthepatic PH in 4 cases (3.8%); the common diseases in patients with prehepatic ph were pancreaticogenic diseases in 22 cases (31.9%), portal vein obstruction in 15 cases (21.7%), and hematologic diseases in 15 cases (21.7%); the main diagnostic methods were imaging examination in 28 cases (40.6%), gastrointestinal endoscopy in 14 cases (20.3%) and bone marrow biopsies in 12 cases (17.4%); the top three methods for the etiological diagnosis in patients with NCPH were imaging examination (33.3%), comprehensive analysis (18.1%) and gastrointestinal endoscopy (13.9%). Conclusion The prehepatic PH should be considered firstly in patients with NCPH presentation, the laboratory and imaging examinations should be performed routinely, and the gastrointestinal endoscopy and bone marrow biopsy might be performed if necessary. For those without clear diagnosis after routine examination, the hepatic and posthepatic PH must be considered, and liver biopsy and inferior vena cava puncture angiography should be done for further validation of diagnosis.

Key words: Non-cirrhotic portal hypertension, Etiology, Diagnostic roadmap